Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Optogenetics
Biotech
How Nobel-winning optogenetics is being harnessed by biotechs
Fierce spoke to Nobel Prize winner Karl Deisseroth, M.D., Ph.D., and other optogenetics pioneers to discover how this science could benefit patients.
Darren Incorvaia
Oct 9, 2026 9:30am
Trio of scientists win Nobel Prize for neuron light switch work
Oct 5, 2026 7:15am
Optogenetic platform illuminates aging pathways in cells
Jul 19, 2023 12:58am
Scientists light up the heart to treat afib
Jun 26, 2023 11:30am
Novartis tries to avoid 'me-too' meds in M&A hunt
Jan 19, 2022 4:10pm
Novartis adds 2nd biotech to optogenetics gene therapy portfolio
Sep 21, 2021 1:15am
